Q8CH02
Gene name |
Sugp1 (Sf4) |
Protein name |
SURP and G-patch domain-containing protein 1 |
Names |
Splicing factor 4 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:70616 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
3 structures for Q8CH02
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 1UG0 | NMR | - | A | 165-239 | PDB |
| 1X4O | NMR | - | A | 250-314 | PDB |
| AF-Q8CH02-F1 | Predicted | AlphaFoldDB |
21 variants for Q8CH02
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388987762 | 74 | H>R | No | EVA | |
| rs3388991666 | 94 | K>R | No | EVA | |
| rs3388939026 | 96 | Q>H | No | EVA | |
| rs3411191482 | 149 | P>H | No | EVA | |
| rs3388939074 | 186 | R>I | No | EVA | |
| rs3388984646 | 250 | K>E | No | EVA | |
| rs3388973777 | 308 | K>R | No | EVA | |
| rs235285933 | 310 | D>E | No | EVA | |
| rs261919057 | 323 | F>L | No | EVA | |
| rs214626381 | 324 | P>S | No | EVA | |
| rs13471212 | 326 | P>L | No | EVA | |
| rs3388984715 | 335 | K>N | No | EVA | |
| rs3388984712 | 340 | A>S | No | EVA | |
| rs3399428795 | 392 | V>M | No | EVA | |
| rs3399254235 | 407 | S>T | No | EVA | |
| rs3388973702 | 427 | V>M | No | EVA | |
| rs3388939046 | 467 | Q>H | No | EVA | |
| rs3388969208 | 565 | Y>* | No | EVA | |
| rs3388979925 | 567 | M>R | No | EVA | |
| rs3399205547 | 611 | S>* | No | EVA | |
| rs3388984035 | 627 | A>P | No | EVA |
No associated diseases with Q8CH02
3 regional properties for Q8CH02
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | SWAP/Surp | 185 - 239 | IPR000061-1 |
| domain | SWAP/Surp | 260 - 314 | IPR000061-2 |
| domain | G-patch domain | 558 - 607 | IPR000467 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| spliceosomal complex | Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| RNA binding | Binding to an RNA molecule or a portion thereof. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| mRNA processing | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
| RNA splicing | The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA. |
1 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q8IWZ8 | SUGP1 | SURP and G-patch domain-containing protein 1 | Homo sapiens (Human) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSLKMDNRDV | AGKANRWFGM | AQPKSGKMNM | NILHQEELIA | QKKREIEARM | EQKARQSHVP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SPQPPHPGEI | ADAHNSCISN | KFANDGSFLQ | QFLKLQKAQT | STDSAPRAPP | SMPTPSSLKK |
| 130 | 140 | 150 | 160 | 170 | 180 |
| PLVLSKRTGL | GLSSPTGPVK | NYSHAKQLPV | AHRPSVFQSP | DDDEEEDYEQ | WLEIKVSPPE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GAETRRVIEK | LARFVAEGGP | ELEKVAMEDY | KDNPAFTFLH | DKNSREFLYY | RRKVAEIRKE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| AQKPQAATQK | VSPPEDEEAK | NLAEKLARFI | ADGGPEVETI | ALQNNRENQA | FSFLYDPNSQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GYRYYRQKLD | EFRKAKAGST | GSFPAPAPNP | SLRRKSAPEA | LSGAVPPITA | CPTPVAPAPA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VNPTPSIPGK | PTATAAVKRK | RKSRWGPEED | KVELPPAELA | QRDIDASPSP | LSVQDLKGLG |
| 430 | 440 | 450 | 460 | 470 | 480 |
| YEKGKPVGLV | GVTELSDAQK | KQLKEQQEMQ | QMYDMIMQHK | RAMQDMQLLW | EKALQQHQHG |
| 490 | 500 | 510 | 520 | 530 | 540 |
| YDSDEEVDSE | LGTWEHQLRR | MEMDKTREWA | EQLTQMGRGK | HFIGDFLPPD | ELEKFMETFK |
| 550 | 560 | 570 | 580 | 590 | 600 |
| ALKEGREPDY | SEYKEFKLTV | ENIGYQMLMK | MGWKEGEGLG | TEGQGIKNPV | NKGATTIDGA |
| 610 | 620 | 630 | 640 | ||
| GFGIDRPAEL | SKEDDEYEAF | RKRMMLAYRF | RPNPLNNPRR | PYY |